By introducing both the overexpression vector circ-PITX1 and the glycolysis inhibitor 2-DG into glioma cells, it was demonstrated that circ-PITX1 overexpression promoted the glycolytic process and radiation resistance, but 2-DG counteracted this promotion. This evidence concerns the gene PITX1 and central nervous system cancer.